Detalles de la búsqueda
1.
Overall Survival in Patients With Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial Disparities.
Clin Lymphoma Myeloma Leuk
; 24(2): e1-e12, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923653
2.
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs).
Clin Lymphoma Myeloma Leuk
; 24(3): 177-186, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37996264
3.
Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community setting.
Cancer Med
; 12(17): 17914-17923, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568276
4.
Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs.
Cancer Chemother Pharmacol
; 75(5): 1015-23, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25776905
5.
Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice.
Cancer Chemother Pharmacol
; 67(2): 421-30, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20443002
6.
Liquid chromatography-tandem mass spectrometric assay for the quantitation in human plasma of the novel indenoisoquinoline topoisomerase I inhibitors, NSC 743400 and NSC 725776.
J Pharm Biomed Anal
; 52(5): 714-20, 2010 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20236781
7.
Development, validation and implementation of immobilized metal affinity for phosphochemicals (IMAP)-based high-throughput screening assays for low-molecular-weight compound libraries.
Nat Protoc
; 3(8): 1350-63, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18714303
8.
Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library.
J Pharmacol Exp Ther
; 322(3): 940-7, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17538006
Resultados
1 -
8
de 8
1
Próxima >
>>